Canadian Respiratory Journal / 2017 / Article / Tab 3

Research Article

Impaired Hemorheology in Exacerbations of COPD

Table 3

The EI values of the groups at different shear stresses.

Shear stress
(Pa)
Control group
( = 12)
Newly diagnosed patient groupExacerbation group
( = 16)
Before treatment
( = 13)
After treatment
( = 13)

0.300.06 ± 0.030.06 ± 0.020.05 ± 0.020.04 ± 0.0 0.0390.333
0.530.12 ± 0.050.12 ± 0.050.08 ± 0.040.05 ± 0.0 0.0100.001
0.950.21 ± 0.080.21 ± 0.080.17 ± 0.0570.12 ± 0.0 0.0020.001
1.690.33 ± 0.100.31 ± 0.090.26 ± 0.070.22 ± 0.0 0.0020.001
3.000.41 ± 0.070.40 ± 0.080.36 ± 0.060.32 ± 0.0 0.0010.001
5.330.49 ± 0.050.47 ± 0.060.45 ± 0.060.42 ± 0.0 0.0010.001
9.490.55 ± 0.040.54 ± 0.050.51 ± 0.050.50 ± 0.0 0.0010.003
16.870.60 ± 0.040.59 ± 0.040.57 ± 0.040.55 ± 0.0 0.0060.002
30.000.63 ± 0.040.63 ± 0.040.61 ± 0.040.59 ± 0.0 0.0070.017

Values are expressed as means ± SD; EI: elongation index and Pa: pascal. : difference between the control group, before treatment of newly diagnosed COPD, and the exacerbation group; : difference between the control group, after treatment of newly diagnosed COPD, and the exacerbation group; < 0.05: difference from control, < 0.05: difference from before treatment of COPD, and < 0.05: difference from after treatment of COPD. and are findings via ANOVA whereas other symbols are findings by comparison of two groups.

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.